Can a diabetes drug fix tiny blood vessels in type 1 diabetes?
NCT ID NCT05478707
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tests whether dulaglutide, a drug used in type 2 diabetes, can improve the function of small blood vessels in adults with type 1 diabetes. The goal is to see if it reduces oxidative stress and helps blood flow better in muscles. The trial was suspended and aimed to enroll 47 people aged 18-40 with type 1 diabetes for over 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.